Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
INTRODUCTION<br />
k<strong>in</strong>ase 1 (PINK1) (Valente et al. 2004), and DJ-1 (Bonifati et al. 2003). New and crucial<br />
<strong>in</strong>sights <strong>in</strong>to the PD pathogenesis have been supplied by the discovery <strong>of</strong> these genetic<br />
mutations and the improved comprehension <strong>of</strong> dysfunction <strong>of</strong> their abnormally encoded<br />
prote<strong>in</strong>s.<br />
Table 4: Gene loci associated with PD ( * Toulouse and Sullivan 2008, # Schapira 2008)<br />
Locus<br />
(MIM#)<br />
PARK1<br />
(168601)<br />
PARK2<br />
(600116)<br />
PARK3<br />
(602404)<br />
PARK4<br />
(605543)<br />
26<br />
Inheritance<br />
Chromosomal<br />
location<br />
Gene<br />
AD 4q21 SNCA<br />
(mutations)<br />
Onset<br />
Cl<strong>in</strong>ical features<br />
Mid-late Idiopathic PD, low<br />
<strong>in</strong>cidence <strong>of</strong> tremor,<br />
fast progression<br />
AR 6q25.2–q27 Park<strong>in</strong> Early Drug <strong>in</strong>duced<br />
dysk<strong>in</strong>esia, dystonia,<br />
slow progression<br />
AD 2p13 Not known Late Idiopathic PD,<br />
dementia, fast<br />
progression<br />
AD 4q21 SNCA<br />
(duplication /<br />
triplication)<br />
Late Dementia,<br />
autonomic<br />
dysfunction,<br />
postural tremor,<br />
fast progression<br />
Neuropathology a<br />
Nigral degeneration,<br />
with LB<br />
Nigral degeneration,<br />
without LB<br />
Nigral degeneration,<br />
with LB, NFT and<br />
plaques<br />
Nigral degeneration,<br />
with LB, vacuoles <strong>in</strong><br />
neurons<br />
PARK5 AD * 4p14<br />
UCHL1 Mid-late Idiopathic PD * Not reported<br />
(191342)<br />
# 4p15<br />
# Yes<br />
PARK6 AR * 1p36<br />
PINK1 Early Slow progression, Not reported<br />
(605909)<br />
# 1p35<br />
drug-<strong>in</strong>duced<br />
dysk<strong>in</strong>esia<br />
PARK7 AR 1p36 DJ1 Early Slow progression, Not reported<br />
(606324)<br />
psychiatric<br />
symptoms<br />
PARK8 AD * 12q12<br />
LRRK2 Late Idiopathic PD Nigral degeneration,<br />
(607060)<br />
# 12p12<br />
variable features<br />
<strong>in</strong>clud<strong>in</strong>g LB, NFT and<br />
ubiquit<strong>in</strong>ated<br />
<strong>in</strong>clusions<br />
PARK9 b<br />
AR * 1p36<br />
ATP13A2 Juvenile Spasticity,<br />
Striatal atrophy<br />
(606693)<br />
# 1p32<br />
supranuclear gaze<br />
paralysis, dementia<br />
PARK10 AD * 1p<br />
Not known Late Not reported Not reported<br />
(606852)<br />
# 1p32<br />
PARK11<br />
(607688)<br />
AD 2q36–q37 Not known Late Not reported Not reported<br />
PARK12 X-l<strong>in</strong>ked Xq21–q25 Not known Not<br />
Not reported Not reported<br />
(300557)<br />
reported<br />
PARK13<br />
(610297)<br />
AD 2p12 Htra2 Late Idiopathic PD Not reported<br />
(601828) 2q22–q23 NR4a2 Late Idiopathic PD Not reported<br />
(603779) 5q23.1–q23.3 Synphil<strong>in</strong>1 Late Idiopathic PD Not reported<br />
a LB: Lewy bodies, NFT: neur<strong>of</strong>ibrillary tangles, plaques: amyloid plaques.<br />
b PARK9 <strong>in</strong>itially presented as idiopathic PD but is now known as Kufor–Rakeb syndrome.